Advancing healthcare, needle-free diagnostics employ wearable biosensors for noninvasive testing, ensuring rapid results and broader access to care.
The Global Brain Cancer Diagnostics Market presents opportunities in AI-driven precision diagnostics and non-invasive liquid biopsies, driven by an aging population and rising tumor incidences.